# Novartis names Firmenich CEO as chairman designate of Sandoz
Published: 2023-02-20
Category: Headlines
Category URL: https://companiesdigest.com/category/headlines/
Meta Title: Novartis appoints Gilbert Ghostine as Sandoz chairman-designate
Meta Description: Novartis appoints Firmenich CEO Gilbert Ghostine as chairman-designate of Sandoz, the generics unit to be spun off in 2023. Exciting developments ahead!
URL: https://companiesdigest.com/novartis-names-firmenich-ceo-as-chairman-designate-of-sandoz/

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qsutv4003uwirgbjchzj7a/images/2023-02-20t063359z1lynxmpej1j04irtroptp4novartis-cancer-prostate-1737056562339-compressed.jpg)

ZURICH (Reuters) – Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics unit Novartis wants to spin off later this year.

Ghostine has been CEO of Geneva-based Firmenich, the world’s largest privately owned perfume and taste company, since 2014.

He will become the chairman of the new board at Sandoz, which is to be formed after its spin-off from Novartis in the second half of 2023, subject to final Novartis Board of Directors and shareholder approvals.

(Reporting by John Revill; Editing by Paul Carrel)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---